Advances in monoclonal antibody therapeutics

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets, is playing a crucial role in the pharmaceutical industry. This trend shows the strong focus of top biopharmaceutical companies in biologics, including monoclonal antibody therapeutics. This research service discusses the emerging trends in monoclonal antibody therapeutics on a global scale, through a detailed strategic assessment of the industry environment.

Table of Contents

Executive SummaryResearch ScopeResearch MethodologyKey FindingsMonoclonal AntibodiesA Sneak Preview Technology Snapshot – Multiple SegmentationIndustry Overview – Main InnovationsIndustry Overview – Main InnovatorsTechnology Roadmap Toward Precision MedicineStrategic Assessment of the Industry EnvironmentTherapeutic Areas and Clinical IndicationsMolecular Agents and Cell TargetsDevelopmental Stage FocusMarket PotentialMarket EvolutionVenture Capital InvestmentCompany Stage Investment FocusGovernment Funding and SupportWorldwide LandscapeKey Drivers and RestraintsKey Technical and Business ChallengesIndustry Best Practices and Strategic InsightsIndustry Assessment – Partnerships and AlliancesStakeholder Assessment for PartnershipsPartnerships and Alliances ModelsPartnerships and CollaborationsPartnerships and Collaborations (continued)Partnerships and Collaborations (continued)Patent AnalysisPatent publishing trendsPatent office-wise distributionStrategic Evaluation of R&D PortfolioR&D Success and Key Performance IndicatorsAnalytical Hierarchy Process (AHP)Analytical Hierarchy Process (AHP)Analytical Hierarchy Process (AHP)Analytical Hierarchy Process (AHP)Analytical Hierarchy Process (AHP)Analytical Hierarchy Process (AHP)Analytical Hierarchy Process (AHP)Analytical Hierarchy Process (AHP)Analytical Hierarchy Process (AHP)Key ContactsContactsContacts (continued)AppendixStrategic R&D Pipeline – The Road AheadR&D Pipeline AssessmentR&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)R&D Pipeline Assessment (continued)Product Line AssessmentProduct Line Assessment (continued)Product Line Assessment (continued)Product Line Assessment (continued)Product Line Assessment (continued)Product Line Assessment (continued)Product Line Assessment (continued)Product Line Assessment (continued)Product Line Assessment (continued)Product Line Assessment (continued)AbbreviationsLegal DisclaimerThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 10-Nov-17

Region : Global

Release Date : 10-Nov-17

Region : Global

Release Date : 09-Nov-17

Region : Global

Release Date : 03-Nov-17

Region : Global

Release Date : 31-Oct-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.